H

Halozyme Therapeutics

San Diego, United States Founded 1998 NASDAQ: HALO

About

ENHANZE technology enabling subcutaneous delivery of biologics

Company Details

Type
public
Employees
500+
Funding
Public

Key Products

  • ENHANZE
  • Hylenex
Visit Website

Related Companies